CO280 Solutions Celebrates the ‘Strong Performance’ of Carbon Removal Tech

Vancouver-based clean technology startup, CO280 Solutions, has recently announced the completion of a successful field pilot program with a pulp and paper producer located on the U.S. Gulf Coast. The pilot aimed to test their liquid amine technology, designed to capture biogenic carbon dioxide from recovery boiler emissions. An impressive 95% efficiency rate was achieved during the test, which was conducted alongside Norway’s SLB Capturi, a company specializing in carbon capture technology. This accomplishment paves the way for the large-scale deployment of these technologies across the pulp and paper industry.

The success of the project was echoed by Jonathan Rhone, CO280’s CEO, who expressed his optimism in leading global carbon removal efforts. With commitments from major buyers like JPMorganChase and Microsoft, which have agreed to purchase significant quantities of carbon dioxide removal credits, CO280 is set to expand its projects further across U.S. and Canadian mills. Founded in 2021, CO280 is now developing over 10 new carbon capture initiatives, underscoring their dedication to creating sustainable and scalable environmental solutions.

For the full source, visit Techcouver.com.

As Distractions Rise, Shift Reimagines the Browser as a Tool for Productivity

Consumers are expressing fatigue with outdated technology and seeking more control over their online experience, according to a recent report from Victoria-based Shift Technologies. The 2026 State of Browsing Report emphasizes that traditional web browsers, initially intended as productivity tools, are now often sources of distraction. The report highlights that more than 60% of North American users experience occasional or regular digital burnout, spurred by constant tab-switching and excessive notifications. Neil Henderson, CEO of Shift, notes the need for browsers that adapt to modern, fragmented online habits rather than follow a one-size-fits-all approach.

In response to this growing demand, Shift has pioneered a customizable browsing experience tailored to high-performance digital users such as founders and creatives. This innovative design allows users to personalize their browsing layout, incorporating features like multiple accounts, task notifications, and “distraction blockers” to enhance productivity. The customizable environment can be adapted to individual workflows, providing a dynamic alternative to traditional static browsers. For more information, visit the original article on Techcouver.com.

Credit Risk Automation Platform Kaaj Raises $3.8M Seed from Kindred Ventures

Kaaj, a company specializing in automating credit risk assessments, has successfully secured a seed funding of $3.8 million from Kindred Ventures and Better Tomorrow Ventures. This financing is aimed at enhancing their platform, which helps financial institutions make quicker and more informed lending decisions. By utilizing advanced technology, Kaaj seeks to simplify the credit evaluation process and increase transparency in the sector.

Both major investors, Kindred Ventures and Better Tomorrow Ventures, express strong confidence in Kaaj’s innovative approach and promising technology. With this new capital, Kaaj plans to expand its team and improve its product, aiming to establish a significant presence in the fintech industry. This strategic move is expected to solidify their position as a key player in financial technology. For more details, visit the official TechCrunch article.

Onepot AI Obtains $13M in Funding to Simplify the Creation of Chemical Drugs

Onepot AI has successfully secured $13 million in funding to make the process of developing chemical drugs more straightforward and efficient. The company operates a lab known as POT-1, which focuses on synthesizing small molecules—a vital component in the discovery and creation of new drugs. With this financial injection, Onepot AI is looking to enhance their lab’s capabilities, streamline operations, and introduce novel technologies that will ease the drug development process.

The newly acquired funds will allow Onepot AI to further build its infrastructure and technological strengths, positioning it as a pioneer in the biotech and pharmaceutical technology sectors. By improving its small-molecule synthesis practices within POT-1, the company aims to make the development of new drugs quicker and more cost-effective, setting new benchmarks for drug synthesis. As Onepot AI expands its reach, the company aspires to transform traditional methodologies, making drug development more accessible and reliable across the pharmaceutical industry.

For more information, visit the original article on TechCrunch.

Funding Underrepresented AI Founders

January Ventures is stepping up to support AI founders who come from different backgrounds and might not typically receive funding. While many are pursuing the latest advancements in AI infrastructure, there is a significant need to invest in those with substantial knowledge in industries like healthcare, manufacturing, and supply chain. These founders are often overlooked, yet they hold the potential to create powerful AI solutions.

During the TechCrunch Disrupt 2025 event, Jennifer Neundorfer, a leading partner at January Ventures, shared insights with Dominic-Madori Davis about this innovative approach. They discussed how investing has evolved in today’s AI-driven world and the necessity of building diverse networks. January Ventures is bridging the financing gap by providing early-stage support to these underrepresented entrepreneurs. Read more on TechCrunch.

Function Health Raises $298M Series B at $2.5B Valuation

The rising tide of digital health information—from electronic health records and blood test results to wearable device data—continues to expand at a rapid pace. Yet, many individuals encounter difficulties utilizing this expansive information in practical ways to enhance their health. With a vision to simplify, Function Health is committed to consolidating and making this data more accessible for its users, reflecting its innovative approach in the biotech and health sectors.

Recent developments bolster its innovative stance, as demonstrated by a significant $298 million Series B funding round, catapulting the company’s valuation to $2.5 billion. By launching a medical intelligence platform, Function Health takes a step closer to allowing users to effectively manage health information, creating pathways to improved personal health management. This progress underscores the immense value of integrated health data, positioning Function Health as a key player in making health insights actionable for everyday users.

For more information, visit the original article.

Cavela Lands $6.6M to Help Brands Beat Pre-Tariff Manufacturing Costs

Cavela, a forward-thinking startup utilizing AI to enhance manufacturing processes, recently secured $6.6 million in funding to support brands in managing the financial impacts of tariffs and trade uncertainties. The company’s innovative AI agents promise to reduce manufacturing costs by an average of 35%, offering brands an opportunity to regain their competitive market position amidst ongoing economic challenges. This funding round was led by XYZ Venture Capital, with additional backing from SUSA Ventures and other prominent investors.

As recent shifts in U.S. trade policies have led to increased production costs, Cavela’s technology provides valuable insights and automation designed to streamline manufacturing processes. By potentially offsetting these elevated expenses, the company aims to assist brands in maintaining their financial health and market relevance. This investment is expected to further enhance Cavela’s AI capabilities and expand its presence in the market, offering a promising avenue for brands dealing with the economic pressures of changing global trade dynamics.

For more details, visit the original article on TechCrunch.